Method for the preparation of 5-cyanophthalide

Information

  • Patent Grant
  • 6441201
  • Patent Number
    6,441,201
  • Date Filed
    Friday, July 27, 2001
    23 years ago
  • Date Issued
    Tuesday, August 27, 2002
    22 years ago
Abstract
A method for the preparation of 5-cyanophthalide in which 5-carboxyphthalide is reacted with a dehydrating agent, such as thionylchloride, and a sulphonamide, in particular sulfamide. Cyanophthalide is prepared in high yields by a convenient procedure. 5-cyanophthalide is an intermediate used in the preparation of the antidepressant drug citalopram.
Description




The present invention relates to a novel process for the preparation of 5-cyanophthalide which is an intermediate used for the manufacture of the well known antidepressant drug citalopram, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran-carbonitrile.




BACKGROUND OF THE INVENTION




Citalopram is a well known antidepressant drug that has now been on the market for some years and has the following structure:











It is a selective, centrally active serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor, accordingly having antidepressant activities. The antidepressant activity of the compound has been reported in several publications, eg. J. Hyttel,


Prog. Neuro


-


Psychopharmacol.


&


Biol. Psychiat.,


1982, 6, 277-295 and A. Gravem,


Acta Psychiatr. Scand.,


1987, 75, 478-486.




Citalopram may be prepared by the process described in U.S. Pat. No. 4,650,884, according to which 5-cyanophthalide is subjected to two successive Grignard reactions, i.e. with 4-fluorophenyl magnesium halogenide and N,N-dimethylaminopropyl magnesium halogenide, respectively, and the resulting compound of the formula











is subjected to a ring closure reaction by dehydration with strong acid.




Enantiomers of citalopram may be prepared by the method described in U.S. Pat. No. 4,943,590, i.e. by separating the enantiomers of the intermediate of Formula II and performing enantioselective ring closure in order to obtain the desired enantiomer.




Thus, 5-cyanophthalide is an important intermediate for the manufacture of citalopram and it is important to produce this material in an adequate quality, by a convenient process and in a cost-effective way.




A method for the preparation of 5-cyanophthalide has previously been described in


Bull. Soc. Sci. Bretagne,


1951, 26, 35 and in Levy and Stephen,


J. Chem. Soc.,


1931, 867. By this method, 5-aminophthalide is converted to the corresponding 5-cyanophthalide by diazotation followed by reaction with CuCN. 5-Aminophthalide was obtained from 4-aminophthalimide by a two step reduction procedure.




Synthesis of certain alkyl- and phenylnitriles from acid chlorides is described in


Tetrahedron Letters,


1982, 23, 14, 1505-1508, and in


Tetrahedron,


1998, 54, 9281.




Though a number of other methods failed, it has now been found that 5-cyanophthalide may be prepared in high yields by a convenient, cost-effective one-pot procedure from 5-carboxyphthalide.




DESCRIPTION OF THE INVENTION




Accordingly, the present invention provides a novel method for the preparation of 5-cyanophthalide











comprising reaction of 5-carboxyphthalide











with a dehydrating agent and a sulfonamide of the formula H


2


N-SO


2


-R (Formula V) wherein R is




a) NH


2


, C


1-6


alkyloxy, phenyloxy,




b) phenyloxy substituted with halogen, C


1-4


-alkyl, cyano, hydroxy, C


1-4


-alkoxy, trifluoromethyl, nitro, amino, C


1-4


-alkylamino or di-C


1-4


-alkylamino, or




c) phenyl substituted with one or more electron withdrawing substituents in order to obtain 5-cyanophthalide.




Any suitable dehydrating agent may be used and the optimal agent may easily be determined by a person skilled in the art. Examples of suitable dehydrating agents are SOCl


2


, POCl


3


, PCl


5


, SOBr


2


, POBr


3


, PBr


5


, SOI


2


, POI


3


, PI


5


and oxalylchloride. Preferably a chloro-containing agent, most preferably SOCl


2


, is used.




The term electron withdrawing substituent is intended to mean any substituent that is sufficiently electron withdrawing to allow the reaction to proceed, such as nitro, cyano, halogen, trifluoromethyl or aminosulfonyl. 3,5-Dinitrophenyl is an example of such a phenyl group substituted with electron withdrawing substituents.




In the method of the invention, the 5-carboxyphthalide reacts with the dehydration agent in order to form the corresponding 5-haloformyl derivative which then reacts with the sulfonamide of the formula V thereby forming the 5-cyanophthalide. During the latter reaction, a catalytic amount of an acid may be necessary. The 5-haloformyl derivative may, if desired, be isolated prior to further reaction. However, preferably the reaction is carried out as a one-pot procedure without isolation of the 5-haloformyl intermediate. Preferably the reaction proceeds via the 5-chloroformylphthalide.




The sulfonamide of Formula V used in the process is preferably sulfamide, i.e. a compound of Formula V wherein R is NH


2


.




The reaction is carried out neat or in a suitable solvent, such as sulfolane or acetonitrile. Preferably, sulfolane is used as the solvent.




Thus, in a preferred embodiment of the invention, 5-carboxyphthalide is reacted with sulfamide in the presence of SOCl


2


in a sulfolane solution




The reaction is carried out at elevated temperature. When sulfolane is used as the solvent, the reaction is preferably carried out at about 120-150° C.




5-Cyanophthalide may be isolated in a conventional way, e.g. by addition of water, filtration and subsequent washing of the crystals. Further purification may if desired be performed by recrystallisation.




Conveniently, 1.0 to 2.0 equivalents of sulfamide and dehydrating agent, respectively, are reacted with 1.0 equivalent 5-carboxyphthalide. Preferably, 1.0-1.2 equivalent sulfamide is used.




By the process of the invention, 5-cyanophthalide is obtained in high yields (>about 70%). The process is much more convenient than the known process and uses more convenient and cheaper reactants and conditions. Furthermore, due to the fact that the process is a one-pot procedure the capacity is substantially increased and accordingly the costs are substantially reduced.




The 5-carboxyphthalide used as a starting material may be obtained by the methods described in U.S. Pat. No. 3,607,884 or German patent No. 2630927, i.e. by reacting a concentrated solution of terephthalic acid with formaldehyde in liquid SO


3


or by electrochemical hydrogenation of trimellithic acid.











EXAMPLES




The invention is further illustrated by the following examples.




Example 1




5-Cyanophthalid




5-Carboxyphthalid (50 g, 0.28 mole) and sulfamide (31 g, 0.32 mole) were suspended in sulfolane (150 mL). Thionylchloride (41 g, 0.34 mole) was added and the temperature was raised to 130-140° C. for 2 hours. At about 90° C., gas evolution took place. The mixture was allowed to cool to 90° C. and water (150 mL) was added. The temperature was held at 85-90° C. for 15 min and then the solution was cooled to 35° C. The crystals were filtered off and washed with water (250 mL). The title compound was crystallised from acetic acid.Yield: 34.5 g, 77%. DSC onset: 203° C. Purity: 98.5% (hplc, peak area).


1


H NMR (DMSO-d


6


, 500 MHz): 5.48 (2H, s), 8.03 (2H, s), 8.22 (1H, s).


13


C NMR (DMSO-d


6


, 125 MHz): 70.0, 116.1, 188.0, 126.0, 127.5, 129.0, 132.8, 147.7, 169.3.




Example 2




5-Cyanophthalid




Wet 5-carboxyphthalid (14 kg, approx. 6.3 kg dry, 35 mole) was suspended in sulfolane (23.5 kg). The water was removed by azeotropic distillation with toluene. Sulfamide (3.9 kg, 41 mole) and thionyl chloride (5.8 kg, 48 mole were added and the temperature was raised to 135-140° C. for 5 hours. At about 90° C. gas evolution took place. The mixture was allowed to cool to 90° C. and water (21.3 kg) was added. The temperature was held at 85-90° C. for 15 min and then the solution was cooled to 35° C. The crystals were filtered off and washed with water (14.2 kg). The title compound was crystallised from acetic acid. Yield: 3.8 kg, 68%. Purity: 99.5% (hplc, peak area).




Example 3




5-Cyanophthalid




5-Chlorocarbonylphthalid (24.3 g, 0.124 mole) was dissolved in sulfolane (51 g). Sulfamide (13.8 g 0.144 mole) was added and the temperature was raised to 135° C. for 3 hours. At about 90° C., gas evolution took place. The mixture was allowed to cool and water (100 g) was added. The temperature was held at 85-90° C. for 5 min and then the solution was cooled to 60° C. The crystals were filtered off and washed with water (60 g) and acetic acid (30 g). Then the title compound was dried in vacuo. Yield: 19 g, 96%. Purity: 98.2% (hplc, peak area).



Claims
  • 1. A method for the preparation of 5-cyanophthalide comprising reaction of 5-carboxyphthalide with a dehydrating agent and a sulfonamide of the formula H2N-SO2-R (Formula V) wherein R isa) NH2, C1-6 alkyloxy, phenyloxy; b) phenyloxy substituted with halogen, C1-4-alkyl, cyano, hydroxy, C1-4-alkoxy, trifluoromethyl, nitro, amino, C1-4-alkylamino or di-C1-4-alkylamino; or c) phenyl substituted with one or more electron withdrawing substituents.
  • 2. The method of claim 1 wherein the dehydrating agent is selected from the group consisting of SOCl2, POCl3, PCl5, SOBr2, POBr3, PBr5, SOI2, POI3, OI5 or oxalylchloride.
  • 3. The method of claim 2 wherein the dehydrating agent is selected from the group consisting of SOCl2, POCl3 or PCl5.
  • 4. The method of claim 3 wherein the dehydrating agent is SOCl2.
  • 5. The method of any of claims 1-3 wherein the sulfonamide used is a compound of Formula V wherein R is NH2.
  • 6. The method of any of claims 1-3 wherein the reaction is carried out without isolation of the 5-haloformylphthalide intermediate.
  • 7. The method of any of claims 1-3 wherein the reaction is carried out neat.
  • 8. The method of claim 1 wherein the reaction is carried out in sulfolane or acetonitrile.
  • 9. The method of claim 8 wherein the reaction is carried out in sulfolane.
  • 10. The method of claim 6 wherein 5-carboxyphthalide is reacted with sulfamide in the presence of SOCl2 in a sulfolane solution.
  • 11. The method of any of claims 1-3 wherein the 5-haloformylphthalide intermediate resulting from the reaction of 5-carboxyphthalide with dehydrating agent is isolated and then reacted with the sulfonamide.
  • 12. The method of claim 11 wherein the reaction is carried out in sulfolane.
Priority Claims (1)
Number Date Country Kind
1999 00128 Jan 1999 DK
Parent Case Info

This is a continuation of international application Ser. No. PCT/DK00/00032, filed Jan. 26, 2000, the entire disclosure of which is hereby incorporated by reference.

US Referenced Citations (15)
Number Name Date Kind
3467675 Petersen et al. Sep 1969 A
4136193 Bogeso et al. Jan 1979 A
4650884 Bogeso Mar 1987 A
4943590 Boegesoe et al. Jul 1990 A
5296507 Tanaka et al. Mar 1994 A
6020501 Massonne et al. Feb 2000 A
6028204 Massonne et al. Feb 2000 A
6229026 Petersen May 2001 B1
6258842 Petersen et al. Jul 2001 B1
6291689 Petersen et al. Sep 2001 B1
20010027256 Petersen et al. Oct 2001 A1
20020004604 Petersen et al. Jan 2002 A1
20020019546 Petersen et al. Feb 2002 A1
20020025982 Petersen et al. Feb 2002 A1
20020026062 Petersen et al. Feb 2002 A1
Foreign Referenced Citations (13)
Number Date Country
WO 0039112 Jun 2000 DK
1 095 926 May 2001 EP
9819511 May 1998 WO
9819512 May 1998 WO
9819513 May 1998 WO
9930548 Jun 1999 WO
0011926 Mar 2000 WO
0012044 Mar 2000 WO
0013648 Mar 2000 WO
0023431 Apr 2000 WO
0145483 Jun 2001 WO
0147877 Jul 2001 WO
0166536 Sep 2001 WO
Non-Patent Literature Citations (15)
Entry
U.S. patent application Ser. No. 09/830,109, filed Oct. 19, 1999 (International filing date).
U.S. patent application Ser. No. 09/891,874, filed Jun. 25, 2001.
U.S. patent application Ser. No. 09/692,653, filed Oct. 19, 2000.
U.S. patent application Ser. No. 09/977,920, filed Oct. 15, 2001.
U.S. patent application Ser. No. 10/012,054, filed Nov. 6, 2001.
U.S. patent application Ser. No. 10/012,025, filed Nov. 6, 2001.
U.S. patent application Ser. No. 10/035,005, filed Dec. 20, 2001.
U.S. patent application Ser. No. 10/046,126, filed Jan. 8, 2002.
Bigler, Allan et al., “Quantitative Structure-activity Relationships in a Series of Selective 5-HT uptake inhibitors,” Eur. J. Med. Chem. 3:289-295 (1997).
Forney L., “Reaction of Terephthalic Acid with Formaldehyde in Sulfur Trioxide Media,” J. Org. Chem. 35:1695-1696 (1970).
Dordor et al., “Reaction of Oxazolines with Phosphorus Oxychloride,” Tetrahedron Letters 24:1437-1440 (1983).
Barton et al., Comprehensive Organic Chemistry. The Synthesis and Reactions of Organic Compounds, vol. 2, pp. 1024-1025.
Huber et al., “Preparation of Nitriles from Carboxylic Acids: A New, Synthetically Useful Example of the Smiles Rearrangement,” Tetrahedron 54: 9281-9288 (1998).
“Phtalides substitués en 5,” Bull. Soc. Sci. Bretagne 26: 35-43 (1951).
Levy et al., “Aminophthalide and Some Derivatives,” Chemistry Society. London Journal 867-871 (1931).
Continuations (1)
Number Date Country
Parent PCT/DK00/00032 Jan 2000 US
Child 09/917180 US